We're building the leading extracellular protein degradation company leveraging our lysosomal targeting chimeras, or LYTAC, platform.

Biotechnology

Lycia Therapeutics

Aetna Wun Trombley

Nadia Tchao

Larry Rozsnyai

Patricia Chang

Winsome Chung

Matt Holdren

Darrin Lindhout

Steve Staben

The Scientific Research Team at Lycia Therapeutics drives the development and optimization of the lysosomal targeting chimeras (LYTAC) platform. This team conducts rigorous experimental research, designs and synthesizes chemical compounds, and performs detailed analyses to target and degrade extracellular proteins, advancing the company’s innovative therapeutic solutions.

Scientific Research Team

Directors Team

Research and Development

Scientific Research Team

About

Team members

Other teams at Lycia Therapeutics

Directors Team

Research and Development